BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18633616)

  • 1. The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas.
    Chen YP; Chang KC; Su WC; Chen TY
    Ann Hematol; 2008 Dec; 87(12):985-90. PubMed ID: 18633616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
    Ishida T; Inagaki H; Utsunomiya A; Takatsuka Y; Komatsu H; Iida S; Takeuchi G; Eimoto T; Nakamura S; Ueda R
    Clin Cancer Res; 2004 Aug; 10(16):5494-500. PubMed ID: 15328188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas.
    Chuang SS; Chang ST; Chuang WY; Huang WT; Hsieh PP; Tsou MH; Liao YL; Lin SH; Hsieh YC; Lu CL; Sheu MJ; Liu H
    Am J Surg Pathol; 2009 Aug; 33(8):1230-40. PubMed ID: 19561449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
    Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
    Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
    Li T; Zhang B; Ye Y; Yin H
    Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
    Piccaluga PP; Agostinelli C; Califano A; Carbone A; Fantoni L; Ferrari S; Gazzola A; Gloghini A; Righi S; Rossi M; Tagliafico E; Zinzani PL; Zupo S; Baccarani M; Pileri SA
    Cancer Res; 2007 Nov; 67(22):10703-10. PubMed ID: 18006812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of platelet-derived growth factor-AA and platelet-derived growth factor-alpha receptor in ameloblastomas.
    Sulzbacher I; Wick N; Pichlhofer B; Mazal PR
    J Oral Pathol Med; 2008 Apr; 37(4):235-40. PubMed ID: 18284546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification.
    Sakata K; Fuwa N; Kodaira T; Aratani K; Ikeda H; Takagi M; Nishio M; Satoh M; Nakamura S; Satoh H; Hareyama M
    Radiother Oncol; 2006 May; 79(2):179-84. PubMed ID: 16644044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
    Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
    Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and mutational status of PDGFR in thymic tumours.
    Meister M; Kahl P; Muley T; Morresi-Hauf A; Sebening C; Kern MA; Breinig M; Schnabel P; Dienemann H; Schirmacher P; Rieker RJ
    Anticancer Res; 2009 Oct; 29(10):4057-61. PubMed ID: 19846951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.
    Moriai S; Takahara M; Ogino T; Nagato T; Kishibe K; Ishii H; Katayama A; Shimizu N; Harabuchi Y
    Clin Cancer Res; 2009 Nov; 15(22):6771-9. PubMed ID: 19887486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.